196 related articles for article (PubMed ID: 24279376)
1. Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity.
Shelan M; Abo-Madyan Y; Welzel G; Bolenz C; Kosakowski J; Behnam N; Wenz F; Lohr F
Radiat Oncol; 2013 Nov; 8():276. PubMed ID: 24279376
[TBL] [Abstract][Full Text] [Related]
2. Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.
Kashihara T; Nakamura S; Wakita A; Okamoto H; Inaba K; Umezawa R; Shima S; Tsuchida K; Kobayashi K; Takahashi K; Murakami N; Ito Y; Igaki H; Fujimoto H; Uno T; Itami J
Cancer Med; 2018 May; 7(5):1723-1730. PubMed ID: 29573193
[TBL] [Abstract][Full Text] [Related]
3. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
[TBL] [Abstract][Full Text] [Related]
4. Salvage radiation therapy after radical prostatectomy: survival analysis.
Galla A; Maggio A; Delmastro E; Garibaldi E; Gabriele P; Bresciani S; Di Dia A; Stasi M; Gabriele D
Minerva Urol Nefrol; 2019 Jun; 71(3):240-248. PubMed ID: 30037205
[TBL] [Abstract][Full Text] [Related]
5. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
King CR; Spiotto MT
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668
[TBL] [Abstract][Full Text] [Related]
6. Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis.
Song C; Byun SJ; Kim YS; Ahn H; Byun SS; Kim CS; Lee SE; Kim JS
PLoS One; 2019; 14(4):e0215057. PubMed ID: 30973905
[TBL] [Abstract][Full Text] [Related]
7. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
8. Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study.
Benziane-Ouaritini N; Zilli T; Giraud A; Ingrosso G; Di Staso M; Trippa F; Pommier P; Meyer E; Francolini G; Schick U; Pasquier D; Marc Cosset J; Magne N; Martin E; Gnep K; Renard-Penna R; Anger E; Achard V; Giraud N; Aristei C; Ferrari V; Pasquier C; Zaine H; Osman O; Detti B; Perennec T; Mihoci I; Supiot S; Latorzeff I; Sargos P
Eur Urol Oncol; 2023 Aug; 6(4):390-398. PubMed ID: 37059627
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer.
Botticella A; Guarneri A; Levra NG; Munoz F; Filippi AR; Rondi N; Badellino S; Arcadipane F; Levis M; Ragona R; Ricardi U
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1111-6. PubMed ID: 24744191
[TBL] [Abstract][Full Text] [Related]
10. Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: A cohort study with meta-analysis.
Viani GA; Gouveia AG; Leite ETT; Moraes FY
Radiother Oncol; 2022 Jun; 171():7-13. PubMed ID: 35288228
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):112-8. PubMed ID: 22300563
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.
Hervás A; Gómez-Caamaño A; Casaña M; Gómez-Iturriaga A; Pastor J; Jove J; Mengual JL; Gónzalez-San Segundo C; Muñoz J
Clin Transl Oncol; 2018 Feb; 20(2):193-200. PubMed ID: 28667448
[TBL] [Abstract][Full Text] [Related]
13. Impact of radiation doses on clinical relapse of biochemically recurrent prostate cancer after prostatectomy.
Takano S; Tomita N; Niwa M; Torii A; Takaoka T; Kita N; Uchiyama K; Nakanishi-Imai M; Ayakawa S; Iida M; Tsuzuki Y; Otsuka S; Manabe Y; Nomura K; Ogawa Y; Miyakawa A; Miyamoto A; Takemoto S; Yasui T; Hiwatashi A
Sci Rep; 2024 Jan; 14(1):113. PubMed ID: 38167430
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence.
Fukuda I; Aoki M; Kimura T; Ikeda K
Ir J Med Sci; 2023 Dec; 192(6):2663-2671. PubMed ID: 37097540
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.
Siegmann A; Bottke D; Faehndrich J; Lohm G; Miller K; Bartkowiak D; Wiegel T; Hinkelbein W
Strahlenther Onkol; 2011 Aug; 187(8):467-72. PubMed ID: 21786112
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
Lee EK; Mui WH; Chan AW; Tung Y; Wong FC
Hong Kong Med J; 2018 Jun; 24(3):218-225. PubMed ID: 29807949
[TBL] [Abstract][Full Text] [Related]
17. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
[TBL] [Abstract][Full Text] [Related]
18. Results of Dose-adapted Salvage Radiotherapy After Radical Prostatectomy Based on an Endorectal MRI Target Definition Model.
Zilli T; Jorcano S; Peguret N; Caparrotti F; Hidalgo A; Khan HG; Vees H; Miralbell R
Am J Clin Oncol; 2017 Apr; 40(2):194-199. PubMed ID: 25222076
[TBL] [Abstract][Full Text] [Related]
19. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
20. Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml.
Umezawa R; Ariga H; Ogawa Y; Jingu K; Matsushita H; Takeda K; Fujimoto K; Sakayauchi T; Sugawara T; Kubozono M; Narazaki K; Shimizu E; Takai Y; Yamada S
Radiat Oncol; 2011 Nov; 6():150. PubMed ID: 22053922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
